Morris & Dickson’s ClearCost is designed to give pharmacy leaders greater control and transparency over their drug purchasing decisions. Built to simplify the complex process of evaluating drug spend, ClearCost provides real-time access to net pricing so decision-makers can see true acquisition costs, rebates, and discounts across multiple purchasing channels. Unlike traditional purchasing contracts, ClearCost® removes generic compliance ratio requirements and eliminates penalties for non-source items, giving pharmacy owners the flexibility to shop the open market without restrictions.
ClearCost integrates seamlessly with M&D’s robust distribution network, ensuring rapid product availability and minimizing backorders. Backed by M&D’s expanded sourcing for generics, branded, specialty, and biosimilars and state-of-the-art distribution capabilities, ClearCost helps pharmacies stay competitive while simplifying procurement.
ClearCost Benefits:
• No required Generics compliance ratio or purchase volume
• Complete transparent model
• Credit issued as often as daily (pharmacy discretion)
• No Generic source designation
• Zero items will be substituted without pharmacy’s approval
Today, more than 500 independent pharmacy owners already participate in ClearCost, using it to optimize purchasing strategies, enhance profitability, and stay competitive in a rapidly evolving marketplace.
